Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression (DEPRECOVID)

Postnatal depression is an important problematic in French population with approximatively 10 -20% of women who suffer from postnatal depression. This pathology may have strong negative impact on both women and neonate's health.

The women's satisfaction degree in front of childbirth is an important factor associated with postnatal depression since women unsatisfied of their childbirth and/or women with a complicated childbirth are more encline to suffer from postnatal depression.

It is likely that the actual context of Covid 19 pandemia and the change in obstetrical cares organization may have a negative impact on women's satisfaction about their childbirth and so a negative impact on the risk of postnatal depression.

Study Overview

• Status: Completed
• Conditions: Postnatal Depression
• Intervention / Treatment: Other: Assessment of postnatal depression using the the Edinburgh questionnaire between 4 and 6 weeks after delivery

• Study Type: Observational
• Enrollment (Actual): 501

Contacts and Locations

Study Locations

• France
  • Poitiers, France
    • Bertrand GACHON

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 50 years (Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

Women who deliver of a single baby, at term and in cephalic presentation whatever is the modalities of delivery (instrumental, cesarean, spontaneous delivery) will be included after their delivery.

Premature and non cephalic birth will be excluded because they are specific deliveries that may be assoictaed with a specific maternal anxietey. Women with psychiatric disorders are excluded since we investigated the occurrence of postnatal depression which is a psychiatric disorder.

Women without any internet access are excluded because women will have to fill online questionnaires. Finally women will be informed, as well as their doctors, in case of postnatal depression with an advice of planning a medical consultation.

Description

Inclusion Criteria:

• women older than 18 years
• women who deliver of a singleton, term neonate in cephalic presentation

Exclusion Criteria:

• women younger than 18 years
• women who deliver of a baby in non cephalic presentation
• women with pre term Birth
• women without any internet access
• women with psychiatric disorders
• women who do not understand french language
• women who refuse to be aware of the results of the postnatal depression screening and who refuse that her doctor be ware of the results

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Report postnatal depression between 4 of 6 weeks during the covid 19 pandemia	proportion of women with an Edinburgh score higher than 12 between 4 and 6 weeks postpartum	4-6 weeks postpartum

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Report factors associated with postnatal depression between 4 of 6 weeks during the covid 19 pandemia	Existence of an association with postnatal depression and these factors: socio demographic women's characteristics, modalities of pregnancy management, satisfaction and experience about delivery, postnatal pelvic floor disorders, self rated health for the woman and the child, modalities of delivery, prenatal anxiety	4-6 weeks postpartum
Describe the experience and the satisfaction about delivery during the covid 19 pandemia	Scale from 0 to 10 of satisfaction ; answers to the WOMBLSQ4 questionnaire about childbirth experience and satisfaction	within the week after delivery

Collaborators and Investigators

• Sponsor: Poitiers University Hospital

Study record dates

Study Major Dates

• Study Start (Actual): April 29, 2020
• Primary Completion (Actual): October 21, 2020
• Study Completion (Actual): November 27, 2020

Study Registration Dates

• First Submitted: April 28, 2020
• First Submitted That Met QC Criteria: April 28, 2020
• First Posted (Actual): April 29, 2020

Study Record Updates

• Last Update Posted (Actual): January 26, 2021
• Last Update Submitted That Met QC Criteria: January 25, 2021
• Last Verified: April 1, 2020

More Information

Terms related to this study

• Keywords: satisfaction; covid 19; childbirth
• Additional Relevant MeSH Terms: Behavioral Symptoms; Mental Disorders; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Mood Disorders; Pneumonia, Viral; Pneumonia; Lung Diseases; Pregnancy Complications; Puerperal Disorders; Depression; Depressive Disorder; COVID-19; Depression, Postpartum
• Other Study ID Numbers: 2020-A01065-34

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No